Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors
US11078171B2 · kind B2 · utility
11Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 11, 2020 |
| Grant date | Aug 3, 2021 |
| Priority date | — |
| Expiry date | May 11, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds that inhibit p38α MAPK protein, and methods of using the same, are provided for treating or preventing diseases such as cancer or inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.